In 2023, Kendra Adams earned $550.00K in total compensation at C4 Therapeutics, primarily from $550.00K salary. Most recently acquired 36,700 shares in Feb 2024. Currently holds stock worth $440.86K. 2+ years at the helm of C4 Therapeutics.
Compensation History
Annual executive compensation data for Kendra Adams, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$550.00K
Salary
$550.00K
Bonus
$0.00
Other
$0.00
Salary
$550.00KBoard Justification
The compensation philosophy emphasizes aligning executive compensation with company performance and market competitiveness, focusing on attracting and retaining top talent.
Bonus
$0.00Board Justification
No bonus was awarded for the year 2023.
Other Compensation
$0.00Board Justification
No other compensation was reported for 2023.
Restricted Stock
Board Justification
No stock was vested in 2023 as the focus was on other compensation elements.
Performance Metrics
The performance metrics for Kendra Adams' compensation were not explicitly stated for 2023.
Kendra Adams
CEO of C4 Therapeutics
Education
B.A. in economics from Hamilton College
Field of Expertise
Finance & Banking - Finance
Sector of Economy
Healthcare
CEO of C4 Therapeutics for
2 years 2 months (Sep 2023 - Present)
Previous Experience
Vice President, Investor Relations and External Communications at Agios Pharmaceuticals; investor relations roles at Ariad Pharmaceuticals and Amgen; finance roles at KPMG LLP and General Electric.
Other C4 Therapeutics CEOs
Holdings
Track Kendra Adams's stock holdings and portfolio value over time.
Insider Trading
Kendra Adams's recent stock transactions, purchases, and sales filed with the SEC.
36,700 shares
CCCC
Feb 13, 2024
Received
25,000 shares
CCCC
Sep 18, 2023
Received
Rivals
Compare Kendra Adams with competitor CEOs and industry peers.